News Focus
News Focus
Followers 308
Posts 37314
Boards Moderated 1
Alias Born 11/14/2013

Re: exwannabe post# 714464

Tuesday, 08/20/2024 11:35:06 AM

Tuesday, August 20, 2024 11:35:06 AM

Post# of 823221
DCVax-l for rGBM will* be a therapy unto its own. It follows recurrence. Regardless of whether it was preceded by Temodar (control group in trial) DCVax-l with Temidar, or something else.

(When likely approved)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News